NASDAQ (usa) |
![]() |
6715.56 | -12.11 | -0.18% |
FTSE 100 (london) |
![]() |
7487.96 | -5.12 | -0.07% |
DAX (german) |
![]() |
13465.51 | 235.94 | 1.78% |
NIKKEI 225 (japan) |
![]() |
22420.08 | 408.47 | 1.86% |
Hang - Seng (hong kong) |
![]() |
28594.06 | 348.52 | 1.23% |
NIFTY - 50 (india) | ||||
Straits Times (singapore) |
![]() |
3391.61 | 17.53 | 0.52% |
KOSPI (korea) |
![]() |
2556.47 | 33.04 | 1.31% |
All Ordinaries (australia) |
![]() |
6005.30 | 28.90 | 0.48% |
BOVESPA (brazil) |
![]() |
74092.76 | -215.73 | -0.29% |
Artelo Biosciences Inc (NASDAQ: ARTLW)
ARTLW Technical Analysis
5
As on 17th Jun 2024 ARTLW STOCK Price closed @ 0.01 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 0.10 & Strong Sell for SHORT-TERM with Stoploss of 0.15 we also expect STOCK to react on Following IMPORTANT LEVELS. |
ARTLWSTOCK Price
Open | 0.01 | Change | Price | % |
High | 0.01 | 1 Day | 0.00 | 0.00 |
Low | 0.01 | 1 Week | 0.00 | 0.00 |
Close | 0.01 | 1 Month | -0.01 | -50.00 |
Volume | 29400 | 1 Year | -0.17 | -94.44 |
52 Week High 0.28 | 52 Week Low 0.00 |
NASDAQ USA Most Active Stocks
AMRS | 0.14 | 100.00% |
GNLN | 0.01 | 0.00% |
NVDA | 111.61 | 2.47% |
RNAZ | 0.56 | 36.59% |
LMDX | 0.02 | 0.00% |
PLUG | 0.85 | -2.30% |
HCTI | 0.27 | 68.75% |
AKTS | 0.04 | 0.00% |
TSLA | 280.52 | -0.58% |
LCID | 2.53 | 0.80% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
ARTLW Daily Charts |
ARTLW Intraday Charts |
Whats New @ Bazaartrend |
ARTLW Free Analysis |
|
ARTLW Important Levels Intraday
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
RESISTANCE | 0.01 |
ARTLW Forecast May 2025
4th UP Forecast | 0.22 |
3rd UP Forecast | 0.15 |
2nd UP Forecast | 0.11 |
1st UP Forecast | 0.07 |
1st DOWN Forecast | -0.05 |
2nd DOWN Forecast | -0.09 |
3rd DOWN Forecast | -0.13 |
4th DOWN Forecast | -0.2 |
ARTLW Weekly Forecast
4th UP Forecast | 0.11 |
3rd UP Forecast | 0.08 |
2nd UP Forecast | 0.06 |
1st UP Forecast | 0.04 |
1st DOWN Forecast | -0.02 |
2nd DOWN Forecast | -0.04 |
3rd DOWN Forecast | -0.06 |
4th DOWN Forecast | -0.09 |
ARTLW Forecast2025
4th UP Forecast | 0.82 |
3rd UP Forecast | 0.56 |
2nd UP Forecast | 0.4 |
1st UP Forecast | 0.24 |
1st DOWN Forecast | -0.22 |
2nd DOWN Forecast | -0.38 |
3rd DOWN Forecast | -0.54 |
4th DOWN Forecast | -0.8 |
Artelo Biosciences Inc ( NASDAQ USA Symbol : ARTLW )
Sector : Other And Other Stocks in Same Sector
Sector : Other And Other Stocks in Same Sector
ARTLW Other Details
Segment | EQ | |
Market Capital | 466742.00 | |
Sector | Other | |
Industry | Other | |
Offical website | > echo $website ; ?> |
ARTLW Address
![]() |
ARTLW Latest News
ARTLW Business Profile
Artelo Biosciences, Inc., an ethical biopharmaceutical company, focuses on developing, licensing, and commercializing cannabinoid therapeutic treatments. Its products pipeline includes ART12.11, a cannabidiol composition for the treatment of inflammatory bowel disease, stroke, and rare/orphan diseases; ART26.12, an endocannabinoid transport protein (FABP5) inhibitor for the treatment of breast cancer, prostate cancer, and neuropathic and nociceptive pain; and ART27.13 for the treatment of cancer and cachexia. The company was formerly known as Reactive Medical, Inc. and changed its name to Artelo Biosciences, Inc. in April 2017. Artelo Biosciences, Inc. was founded in 2011 and is based in La Jolla, California. Address:
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service